September 13, 2023 A class action alleges fourteen companies make and/or sell over-the-counter cold and flu medicines with an active ingredient that is ineffective at treating nasal congestion.
![Class Action Claims Maximum Strength Selsun Blue May Cause Scalp Irritation, Hair Loss [UPDATE]](/media/newswire-thumb-sanofi.png)
February 5, 2021 A lawsuit claims the label of Maximum Strength Selsun Blue antidandruff shampoo fails to disclose the product can cause scalp irritation and hair loss.
December 4, 2019 A class action claims Zantac manufacturer Sanofi knew the heartburn drug contained NDMA yet concealed this information from the public.
November 14, 2019 A proposed class action claims Sanofi knowingly manufactured and sold Zantac contaminated with the probable carcinogen N-Nitrosodimethylamine (NDMA).
September 17, 2019 Zantac makers Sanofi-Aventis U.S. and Boehringer Ingelheim face a class action over the allegedly high NDMA content in the over-the-counter heartburn and indigestion drug.
